A detailed history of Laffer Tengler Investments transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Laffer Tengler Investments holds 930 shares of BMY stock, worth $47,355. This represents 0.01% of its overall portfolio holdings.

Number of Shares
930
Previous 1,000 7.0%
Holding current value
$47,355
Previous $54.2 Million 28.78%
% of portfolio
0.01%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $2,817 - $3,709
-70 Reduced 7.0%
930 $38.6 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $3,358 - $3,808
70 Added 7.53%
1,000 $54.2 Million
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $55,028 - $64,458
930 New
930 $55 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $57,576 - $62,700
-930 Closed
0 $0
Q4 2020

Jun 11, 2021

BUY
$57.74 - $65.43 $53,698 - $60,849
930 New
930 $57.6 Million
Q4 2020

Feb 19, 2021

SELL
$57.74 - $65.43 $53,698 - $60,849
-930 Closed
0 $0
Q2 2020

Jun 11, 2021

BUY
$54.82 - $64.09 $50,982 - $59,603
930 New
930 $54.7 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $3.04 Million - $3.5 Million
-50,721 Closed
0 $0
Q3 2017

Nov 16, 2017

BUY
$55.23 - $63.74 $2.8 Million - $3.23 Million
50,721
50,721 $3.23 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $108B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Laffer Tengler Investments Portfolio

Follow Laffer Tengler Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

News

Stay updated on Laffer Tengler Investments with notifications on news.